AUSTIN, Texas–(BUSINESS WIRE)–Texas Original Compassionate Cultivation (TOCC), Texas’ leading medical cannabis provider, today announced it has partnered with Vertosa, a science-first cannabis company that creates the most effective and reliable active ingredients for infused products. TOCC’s proven medical cannabis products will be the first and only in Texas to feature Vertosa’s solutions. TOCC will use…
TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions in legal psychedelics and medical cannabis, announced today it has entered a definitive agreement to acquire 100% of the issued and outstanding shares Lucid Psycheceuticals…
BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), today reported its Q1 financial results. “The Company is on a path of transformation and is well-positioned to drive innovation and our business plan forward as a result of activities that were achieved in this first quarter of 2022,” said Mark Upsdell, CEO,…
BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), today reported its financial results for the year ended February 28, 2021. “The Company achieved a number of key milestones this year, is transitioning efficiently into its commercialization stage from research and development and our IP has expanded to fulfill a number of…
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to provide a corporate update and proforma revenue guidance including its two recently completed acquisitions, APCNA Holdings LLC (“Apothecanna”) and Sagely Enterprises Inc. (“Sagely Naturals”), (together the “Acquisitions”)…
CENTER CITY, Minn.–(BUSINESS WIRE)–New online education courses offered by the Hazelden Betty Ford Foundation aim to help people who are questioning or confused about their substance use, or beginning to experience negative consequences such as understand how marijuana, alcohol and other substance use can contribute to a myriad of life problems and how to make…
MONCTON, New Brunswick–(BUSINESS WIRE)–Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce the launch of SHRED’ems, a high-quality and bold flavoured lineup of cannabis-infused gummies. SHRED’ems is an extension of the Company’s highly popular, value-priced SHRED product…
DUBLIN–(BUSINESS WIRE)–The “Global Hydroponics Market to 2027” report has been added to ResearchAndMarkets.com’s offering. Hydroponics is the process of growing plants by using mineral solution in gravel, sand, without using soil. Increase in success rate related with the commercial hydroponics industry and the rise in difficulty of growing crops on soil, the global hydroponics market…
TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the “Company” or “FSD”) announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (“PEA”), or FSD-201, for use in treating COVID-19. FSD-201 stabilizes mast cells and down-regulates the pro-inflammatory cytokines to effectuate an anti-inflammatory response; it is also known to target the…
HAMILTON, Bermuda–(BUSINESS WIRE)–Bermuda was awarded best non-Asian captive domicile, at Captive Review’s Asia and Pacific (APAC) Virtual Awards and Summit 2021. Bermuda was recently shortlisted alongside: Guernsey, Hawaii, and Vermont, but came through with the win. Roland Andy Burrows, the Bermuda Business Development Agency’s (BDA) CEO, said, “As the world’s premier captive domicile, the BDA…
BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,096,933 titled “Method of Treating Disorders Associated with Chronic Inflammation.” The ’933…
SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is a leading biosynthesis company focused on the research and development of environmentally-friendly products to improve mental health, increase healthspan, and promote longevity. CB Therapeutics is happy to announce that it has been awarded two more patents for the novel methods of production of high value molecules using cutting-edge biosynthesis technologies.…